Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue (HSP, VRX, ELN, KV-A)
Posted in: Markets, Trading Ideas
Below are the top drug delivery stocks on the NYSE in terms of revenue.
The trailing-twelve-month revenue at Hospira Inc (NYSE: HSP) is $3.92 billion. HSP's ROE for the same period is 12.30%.
The trailing-twelve-month revenue at Valeant Pharmceutical International Inc (NYSE: VRX) is $1.18 billion. VRX's operating margin for the same period is 22.36%.
The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $842.70 million. ELN's PEG ratio is 0.46.
The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $149.35 million. KV-A had $25.66 million in total cash for the recent quarter.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
